# Vitamin D Therapy to Prevent Recurrent Preeclampsia in High-Risk Pregnancies

Study · id `cardio:ct-nct07717931` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07717931](<https://clinicaltrials.gov/study/NCT07717931>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07717931

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 146 participants.

## Technical summary

Registry record NCT07717931. Randomized; double masking; primary purpose prevention. Start 2025-08-01 (actual); primary completion 2026-01-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 146 participants (enrolled count; ClinicalTrials.gov record NCT07717931, source copy `cardio:ctgov-nct07717931-2026-07-21`, retrieved 2026-10-26)
- Started: 2025-08-01 (actual) (ClinicalTrials.gov record NCT07717931, source copy `cardio:ctgov-nct07717931-2026-07-21`, retrieved 2026-10-26)
- Primary completion: 2026-01-30 (actual) (ClinicalTrials.gov record NCT07717931, source copy `cardio:ctgov-nct07717931-2026-07-21`, retrieved 2026-10-26)
- Completion: 2026-01-30 (actual) (ClinicalTrials.gov record NCT07717931, source copy `cardio:ctgov-nct07717931-2026-07-21`, retrieved 2026-10-26)
- Countries: Pakistan (ClinicalTrials.gov record NCT07717931, source copy `cardio:ctgov-nct07717931-2026-07-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07717931-2026-07-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Vitamin D Therapy to Prevent Recurrent Preeclampsia in High-Risk Pregnancies
- Condition: Preeclampsia
- Intervention (Drug): Vitamin D (Cholecalciferol )
- Intervention (Drug): Placebo
- Lead sponsor: CMH Multan Institute of Medical Sciences
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: c4acff9d3545a97c17f9d6e0de6499ec32fffa810bc5cbca11f817c0fe3ad680
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
